Nikkei Reported Toyota Is Limiting Orders For Lexus Models In Japan Due To Chip Shortage
https://asia.nikkei.com/Business/Automobiles/Toyota-limits-orders-for-Lexus-in-Japan-due-to-chip-shortage
Immatics Biotechnologies Granted U.S. Patent #11554164: A*03 Restricted Peptides For Use In Immunotherapy Against Cancers And Related Methods
https://www.scribd.com/document/620318568/IMTX-Patent
Biokine Therapeutics Ltd., BioLineRx Ltd. Granted U.S. Patent #11554159: Compositions And Methods For Treating Cancer
https://www.scribd.com/document/620316827/BLRX-Patent
Eastman Kodak Company Granted U.S. Patent #11555129: Ink Set For Inkjet Printing
https://www.scribd.com/document/620305360/Kodak-Patent
Zomedica Announced Expanded Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Zomedica Corp. (NYSE American: ZOM) today announced that in cooperation with Structured Monitoring Products, Inc. (SMP), it will begin commercializing the revolutionary VetGuardian® zero-touch vital signs remote monitoring system for veterinary professionals.
Elon Musk, Tesla Set To Go To Trial Tuesday Over 2018 Tweet That Funding Was Secured to Take the Company Private
https://www.reuters.com/article/tesla-musk-trial/tesla-musk-face-trial-in-shareholder-case-over-2018-tweets-idUSL1N33X2CS
BIT Mining Launched New Energy Efficient LiteCoin/DogeCoin Miner LD3
BIT Mining Limited (NYSE: BTCM) today announced the launch of their state-of-the-art Litecoin ("LTC") / Dogecoin ("DOGE") mining machine, model LD3 ("LD3"), which was specifically designed for mining on the DOGE and LTC blockchains.
Bloomberg Reported Emerson Set To Bid ~$53/Share for National Instruments
https://www.bloomberg.com/news/articles/2023-01-17/emerson-said-set-to-reveal-7-billion-national-instruments-bid?utm_source=google&utm_medium=bd&cmpId=google&sref=y3YMCJ4e&leadSource=uverify%20wall
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
Elicio Therapeutics, a privately-held, clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases, has entered into a definitive merger agreement with Angion Biomedica Corp (NASDAQ: ANGN) under which Elicio will merge with a wholly-owned subsidiary of Angi